Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations
- PMID: 24585383
- DOI: 10.1002/ana.24126
Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations
Abstract
We recently identified DEPDC5 as the gene for familial focal epilepsy with variable foci and found mutations in >10% of small families with nonlesional focal epilepsy. Here we show that DEPDC5 mutations are associated with both lesional and nonlesional epilepsies, even within the same family. DEPDC5-associated malformations include bottom-of-the-sulcus dysplasia (3 members from 2 families), and focal band heterotopia (1 individual). DEPDC5 negatively regulates the mammalian target of rapamycin (mTOR) pathway, which plays a key role in cell growth. The clinicoradiological phenotypes associated with DEPDC5 mutations share features with the archetypal mTORopathy, tuberous sclerosis, raising the possibility of therapies targeted to this pathway.
© 2014 American Neurological Association.
Comment in
-
DEPDC5 does it all: shared genetics for diverse epilepsy syndromes.Ann Neurol. 2014 May;75(5):631-3. doi: 10.1002/ana.24160. Epub 2014 May 8. Ann Neurol. 2014. PMID: 24753000 No abstract available.
Similar articles
-
Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations.Ann Neurol. 2015 Apr;77(4):675-83. doi: 10.1002/ana.24368. Epub 2015 Mar 13. Ann Neurol. 2015. PMID: 25623524
-
Involvement of GATOR complex genes in familial focal epilepsies and focal cortical dysplasia.Epilepsia. 2016 Jun;57(6):994-1003. doi: 10.1111/epi.13391. Epub 2016 May 13. Epilepsia. 2016. PMID: 27173016
-
DEPDC5 mutations in familial and sporadic focal epilepsy.Clin Genet. 2017 Oct;92(4):397-404. doi: 10.1111/cge.12992. Epub 2017 Mar 30. Clin Genet. 2017. PMID: 28170089
-
mTOR signaling pathway genes in focal epilepsies.Prog Brain Res. 2016;226:61-79. doi: 10.1016/bs.pbr.2016.04.013. Epub 2016 Jun 7. Prog Brain Res. 2016. PMID: 27323939 Review.
-
GATOR1 complex: the common genetic actor in focal epilepsies.J Med Genet. 2016 Aug;53(8):503-10. doi: 10.1136/jmedgenet-2016-103883. Epub 2016 May 19. J Med Genet. 2016. PMID: 27208208 Review.
Cited by
-
Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.Nat Med. 2015 Apr;21(4):395-400. doi: 10.1038/nm.3824. Epub 2015 Mar 23. Nat Med. 2015. PMID: 25799227
-
Hypervascularization in mTOR-dependent focal and global cortical malformations displays differential rapamycin sensitivity.Epilepsia. 2019 Jun;60(6):1255-1265. doi: 10.1111/epi.15969. Epub 2019 May 24. Epilepsia. 2019. PMID: 31125447 Free PMC article.
-
The Genetics of Tuberous Sclerosis Complex and Related mTORopathies: Current Understanding and Future Directions.Genes (Basel). 2024 Mar 4;15(3):332. doi: 10.3390/genes15030332. Genes (Basel). 2024. PMID: 38540392 Free PMC article. Review.
-
Frontal lobe seizures: overview and update.J Neurol. 2022 Jun;269(6):3363-3371. doi: 10.1007/s00415-021-10949-0. Epub 2022 Jan 10. J Neurol. 2022. PMID: 35006387 Review.
-
Therapy in Sleep-Related Hypermotor Epilepsy (SHE).Curr Treat Options Neurol. 2020 Jan 30;22(1):1. doi: 10.1007/s11940-020-0610-1. Curr Treat Options Neurol. 2020. PMID: 31997091 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous